The Validity of a New Structured Assessment of Gastrointestinal Symptoms Scale (SAGIS) for Evaluating Symptoms in the Clinical Setting

被引:45
作者
Koloski, N. A. [1 ,2 ,3 ,4 ]
Jones, M. [5 ]
Hammer, J. [1 ,2 ,3 ]
von Wulffen, M. [1 ,2 ,3 ]
Shah, A. [1 ,2 ,3 ]
Hoelz, H. [1 ,2 ]
Kutyla, M. [1 ,2 ]
Burger, D. [1 ,2 ]
Martin, N. [1 ,2 ]
Gurusamy, S. R. [1 ,2 ]
Talley, N. J. [4 ]
Holtmann, G. [1 ,2 ,3 ,6 ]
机构
[1] Princess Alexandra Hosp, Dept Gastroenterol & Hepatol, Ipswich Rd, Brisbane, Qld 4102, Australia
[2] TRI, Ipswich Rd, Brisbane, Qld 4102, Australia
[3] Univ Queensland, Fac Med, Brisbane, Qld 4072, Australia
[4] Univ Newcastle, Fac Hlth & Med, Newcastle, NSW 2308, Australia
[5] Macquarie Univ, Dept Psychol, N Ryde, NSW 2109, Australia
[6] Univ Queensland, Fac Hlth & Behav Sci, St Lucia, Qld 4067, Australia
基金
英国医学研究理事会;
关键词
Questionnaire development; Validation; Irritable bowel syndrome; Quality of life; Gastrointestinal symptoms; IRRITABLE-BOWEL-SYNDROME; GASTROESOPHAGEAL-REFLUX DISEASE; REPORTED OUTCOME MEASURES; CHRONIC PAIN; DISORDERS; PATIENT; QUESTIONNAIRE; VALIDATION; CHALLENGE; DYSPEPSIA;
D O I
10.1007/s10620-017-4599-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The clinical assessments of patients with gastrointestinal symptoms can be time-consuming, and the symptoms captured during the consultation may be influenced by a variety of patient and non-patient factors. To facilitate standardized symptom assessment in the routine clinical setting, we developed the Structured Assessment of Gastrointestinal Symptom (SAGIS) instrument to precisely characterize symptoms in a routine clinical setting. We aimed to validate SAGIS including its reliability, construct and discriminant validity, and utility in the clinical setting. Development of the SAGIS consisted of initial interviews with patients referred for the diagnostic work-up of digestive symptoms and relevant complaints identified. The final instrument consisted of 22 items as well as questions on extra intestinal symptoms and was given to 1120 consecutive patients attending a gastroenterology clinic randomly split into derivation (n = 596) and validation datasets (n = 551). Discriminant validity along with test-retest reliability was assessed. The time taken to perform a clinical assessment with and without the SAGIS was recorded along with doctor satisfaction with this tool. Exploratory factor analysis conducted on the derivation sample suggested five symptom constructs labeled as abdominal pain/discomfort (seven items), gastroesophageal reflux disease/regurgitation symptoms (four items), nausea/vomiting (three items), diarrhea/incontinence (five items), and difficult defecation and constipation (2 items). Confirmatory factor analysis conducted on the validation sample supported the initially developed five-factor measurement model (, p < 0.0001, chi (2)/df = 4.6, CFI = 0.90, TLI = 0.88, RMSEA = 0.08). All symptom groups demonstrated differentiation between disease groups. The SAGIS was shown to be reliable over time and resulted in a 38% reduction of the time required for clinical assessment. The SAGIS instrument has excellent psychometric properties and supports the clinical assessment of and symptom-based categorization of patients with a wide spectrum of gastrointestinal symptoms.
引用
收藏
页码:1913 / 1922
页数:10
相关论文
共 39 条
  • [1] Validation of the gastrointestinal symptom score for the assessment of symptoms in patients with functional dyspepsia
    Adam, B
    Liebregts, T
    Saadat-Gilani, K
    Vinson, B
    Holtmann, G
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 (04) : 357 - 363
  • [2] Agréus L, 2001, AM J GASTROENTEROL, V96, P2905
  • [3] Development and validation of a new disease severity index: the Inflammatory Bowel Disease Index (IBDEX)
    Alrubaiy, Laith
    Dodds, Phedra
    Hutchings, Hayley Anne
    Russell, Ian Trevor
    Watkins, Alan
    Williams, John Gordon
    [J]. FRONTLINE GASTROENTEROLOGY, 2015, 6 (03) : 161 - 168
  • [4] Systematic Review of the Clinical Disease Severity Indices for Inflammatory Bowel Disease
    Alrubaiy, Laith
    Rikaby, Ibtihal
    Sageer, Mohamed
    Hutchings, Hayley Anne
    Williams, John Gordon
    [J]. INFLAMMATORY BOWEL DISEASES, 2015, 21 (10) : 2460 - 2466
  • [5] PSYCHOMETRIC PROPERTIES OF THE SUNYA REVISION OF THE PSYCHOSOMATIC SYMPTOM CHECKLIST
    ATTANASIO, V
    ANDRASIK, F
    BLANCHARD, EB
    ARENA, JG
    [J]. JOURNAL OF BEHAVIORAL MEDICINE, 1984, 7 (02) : 247 - 257
  • [6] Intensity of Chronic Pain - The Wrong Metric?
    Ballantyne, Jane C.
    Sullivan, Mark D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (22) : 2098 - 2099
  • [7] Anxiety and depression as markers of multiplicity of sites of functional gastrointestinal disorders: A gender issue?
    Bouchoucha, Michel
    Hejnar, Maria
    Devroede, Ghislain
    Babba, Thouraya
    Bon, Cyriaque
    Benamouzig, Robert
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2013, 37 (04) : 422 - 430
  • [8] Impact of Functional Gastrointestinal Disorders on Survival in the Community
    Chang, Joseph Y.
    Locke, G. Richard, III
    McNally, Meredythe A.
    Halder, Smita L.
    Schleck, Cathy D.
    Zinsmeister, Alan R.
    Talley, Nicholas J.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (04) : 822 - 832
  • [9] Gender bias in the diagnosis of COPD
    Chapman, KR
    Tashkin, DP
    Pye, DJ
    [J]. CHEST, 2001, 119 (06) : 1691 - 1695
  • [10] Health-related quality of life (HRQOL) questionnaires in gastro-oesophageal reflux disease
    Chassany, O.
    Holtmann, G.
    Malagelada, J.
    Gebauer, U.
    Doerfler, H.
    Devault, K.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (11) : 1053 - 1070